Stock Analiz

Airsculpt Technologies, Inc. AIRS

Medical/Nursing Services · IPO 2021 · data as of November 13, 2026

$0.84Market cap $62M
Open the interactive analysis →

Airsculpt Technologies, Inc. (AIRS) is a healthcare company listed in the US with a market value of about $62M. In the twelve months to September 30, 2026 it had revenue of $148M and net income of -$9M, a net margin of -6.4%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is track record (1/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 19% a year, a 5-year average ROIC of 1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 10% below the current price.

About Airsculpt Technologies

Airsculpt Technologies is listed in the US and classified in medical/nursing services, IPO year 2021. Revenue went from $41M in 2019 to $152M in 2025, growth of about 24.3% a year. It was profitable in 2 of the last 7 years in our data. Its share count rose by 9% over three years (dilution for shareholders).

Score: 0.6 / 5

Value0/5
Future growth0/5
Track record1/5
Financial health1/5
Shareholder returns1/5

Checks passed

  • 5-year revenue growth above 8% a year
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.4
P/B0.6
EV/EBITDA22.5
PEG—
Dividend yield0.00%
FCF yield-4.1%
Shareholder yield0.0%
Intrinsic value vs. price−10%

Growth and quality

Revenue growth (1 yr)-15.8%
Revenue growth (5 yrs, per year)19.3%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)-60.8%
Net margin (5-yr avg.)-3.0%
ROIC (5-yr avg.)1.1%
Profitable years (of last 10)2
Years paying a dividend3

Financials, last 7 years

Fiscal yearTTM2025202420232022202120202019
Revenue$148M$152M$180M$196M$169M$133M$63M$41M
Net income-$9M-$12M-$8M-$4M-$15M$11M$8M-$2M
Free cash flow-$3M$692000-$3M$14M$12M$20M$10M$499000
EPS (diluted)$-0.12$-0.19$-0.14$-0.08$-0.26$-0.01——
Net margin-6.4%-7.7%-4.5%-2.2%-8.7%7.9%12.1%-5.4%
ROIC—-4.5%-0.7%4.2%-2.0%8.3%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Airsculpt Technologies stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 10% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Airsculpt Technologies pay a dividend?

Not currently.

Is Airsculpt Technologies a good stock to buy?

We do not give buy or sell advice. Airsculpt Technologies scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.